Different inhibitor incidence for individual factor VIII concentrates in 1076 previously untreated patients with severe hemophilia A: data from the PedNet cohort
1 Center for Benign Hematology Thrombosis and Hemostasis, Van Creveldkliniek, University Medical Center, Utrecht University, The Netherlands. Electronic address: k.fischer@umcutrecht.nl.
2 Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Canada.
3 Department of Paediatrics, Medical University Hospital of Vienna, Vienna, Austria.
4 Pediatric Coagulation Unit, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
5 Haemophilia-Haemostasis Unit, St. Sophia Children's Hospital, Athens, Greece.
6 National Hemophilia Center, Sheba Medical Center, Tel Hashomer & Amalia Biron Research Institute of Thrombosis & Hemostasis, Tel Aviv University, Israel.
7 Division of Pediatric Hematology & Oncology, Department of Pediatrics, Inselspital, University Hospital, University of Bern, Bern, Switzerland.
8 University Hospital Frankfurt, Department of Paediatrics and Adolescent Medicine, Frankfurt, Germany.
9 Centro de Referência de Coagulopatias Congénitas do Centro Hospitalar Universitário S. João, EPE, Porto, Portugal.
10 Unidad de Coagulopatías, Hopital Universitario La Paz, Madrid, Spain.
11 Julius Clinical, Zeist, The Netherlands.
12 Centre de Traitement de l'Hémophilie, AP-HM, Aix Marseille Université, Marseille, France.
13 PedNet Haemophilia Research Foundation, Baarn, The Netherlands.